Headlines
Business
Markets
Cryptocurrency
Startups
Property
Sports
Athletics
Baseball
Basketball
Boxing
Cricket
Football
Golf
Hockey
Motorsports
Rugby
Soccer
Tennis
Entertainment
Gaming
Gossip
Movies
Music
Television
Technology
Gadgets
Medical
Photography
Science
Space
Style
Fashion
Mens Fashion
Life Style
Popular
This Week
This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer
New England Journal of Medicine
-
19 Oct 2025 02:30
New England Journal of Medicine, Ahead of Print.
Full Article at
New England Journal of Medicine
More
Medical News
0
0
0
Storyboard
Print
Permalink
Share this Article
Recommended
{TITLE}
{PUBLISHER} - {PUBLISHED_DATE}
{VIEWS}
Create Storyboard